» Articles » PMID: 30350168

Biological and Imaging Predictors of Cognitive Impairment After Stroke: a Systematic Review

Overview
Journal J Neurol
Specialty Neurology
Date 2018 Oct 24
PMID 30350168
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cognitive impairment is frequent after stroke, and several studies have suggested that biological and imaging characteristics present before stroke are associated with the development of post-stroke cognitive impairment.

Objective: The aim of our study was to systematically review biological and imaging predictors of cognitive impairment after stroke.

Method: Studies were identified from bibliographic databases and reference lists, and were included if conducted in patients with acute stroke, with at least 30 patients, and a follow-up of at least 3 months. We included articles on potential biomarkers of cognitive impairment that pre-existed to stroke.

Results: We identified 22,169 articles, including 20,349 with abstract. After analysis, 66 studies conducted in 42 cohorts met selection criteria. They included 30-9522 patients [median 170; interquartile range (IQR) 104-251] with a median follow-up of 12 months (IQR 3-36). All studies met quality criteria for description of the study population and standardization of biomarkers. Twenty-nine studies met all quality criteria. There was no convincing evidence that any biological marker may predict cognitive impairment. The most consistent predictors of cognitive impairment after stroke were global atrophy and medial temporal lobe atrophy.

Conclusion: Pre-existing cerebral atrophy is the most consistent predictor of cognitive impairment that can be identified in patients with an acute stroke.

Citing Articles

Functional connectivity and white matter microstructural alterations in patients with left basal ganglia acute ischemic stroke.

Chen M, Wu Y, Wang Y, Li Z Brain Imaging Behav. 2025; .

PMID: 39964657 DOI: 10.1007/s11682-025-00982-2.


The immunology of stroke and dementia.

Iadecola C, Anrather J Immunity. 2025; 58(1):18-39.

PMID: 39813992 PMC: 11736048. DOI: 10.1016/j.immuni.2024.12.008.


Spinal cord electrical stimulation for severe disturbance of consciousness after traumatic brain injury: A case report.

Zhu Z, Hu X, Mao Y Heliyon. 2024; 10(15):e34913.

PMID: 39144968 PMC: 11320212. DOI: 10.1016/j.heliyon.2024.e34913.


Are we ready to cure post-stroke cognitive impairment? Many key prerequisites can be achieved quickly and easily.

Godefroy O, Aarabi A, Bejot Y, Biessels G, Glize B, Mok V Eur Stroke J. 2024; :23969873241271651.

PMID: 39129252 PMC: 11569528. DOI: 10.1177/23969873241271651.


Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention.

Lu Q, Yu A, Pu J, Chen D, Zhong Y, Bai D Front Mol Neurosci. 2024; 17:1375973.

PMID: 38845616 PMC: 11153683. DOI: 10.3389/fnmol.2024.1375973.


References
1.
Martin-Ruiz C, Dickinson H, Keys B, Rowan E, Kenny R, von Zglinicki T . Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol. 2006; 60(2):174-80. DOI: 10.1002/ana.20869. View

2.
Narasimhalu K, Lee J, Leong Y, Ma L, De Silva D, Wong M . Inflammatory markers and their association with post stroke cognitive decline. Int J Stroke. 2013; 10(4):513-8. DOI: 10.1111/ijs.12001. View

3.
Yatawara C, Ng K, Chander R, Kandiah N . Associations between lesions and domain-specific cognitive decline in poststroke dementia. Neurology. 2018; 91(1):e45-e54. DOI: 10.1212/WNL.0000000000005734. View

4.
Tatemichi T, Foulkes M, Mohr J, Hewitt J, Hier D, Price T . Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke. 1990; 21(6):858-66. DOI: 10.1161/01.str.21.6.858. View

5.
Stebbins G, Nyenhuis D, Wang C, Cox J, Freels S, Bangen K . Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke. 2008; 39(3):785-93. DOI: 10.1161/STROKEAHA.107.507392. View